AI for Early Cancer Diagnostics Market

Global AI for Early Cancer Diagnostics Market Size, Trends & Analysis - Forecasts to 2028 By Component (Software Solutions, Hardware and Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor and Others), By End-User (Hospitals, Surgical Centers, Medical Institutes, and Others), By Region (North America, Asia Pacific, and South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on January 27 2023 with the latest and most recent market numbers

Global AI for Early Cancer Diagnostics Market Size

The Global AI for Early Cancer Diagnostics Market is projected to grow at a CAGR of 29.7% from 2023 to 2028.

Artificial intelligence is the ability of a system to carry out tasks that normally require human intelligence. AI assists medical professionals in healthcare diagnostics in making decisions that are right for their patients and delivering effective care. The likelihood of surviving cancer can be increased by early detection and therapy. Cancer is diagnosed and treated using AI techniques. AI-based systems can find patterns in data that users might not notice. The possibility of the onset and spread of cancer can also be predicted using these approaches.

The application of AI for cancer screening and diagnosis makes it feasible to detect cancer early, which is predicted to boost market expansion. In contrast to doctors, who typically rely on the observations gained through their experience, AI/ML models examine images produced by pathology and radiology, which aids in the accurate diagnosis of cancer.

The increasing prevalence of chronic diseases, the shortage of healthcare experts, and the growing demand for AI to be used in medical diagnosis procedures in order to reduce errors are all the factors driving the growth of this market.

Moreover, developing region’s increasing investment on healthcare IT products and services is analyzed to favourably influence market’s growth during the forecast period of 2023-2028. The increased spending is analyzed to contribute to the improvement of the digital infrastructure, which is anticipated to accelerate the use of AI in hospitals and other healthcare facilities. For instance, the number of AI-related financing deals in the life sciences increased from 14 in the first quarter of 2019 to 56 in the first quarter of 2021, according to a pharmaceutical technology article from November 2021. Additionally, AI significantly lowers the cost of treatment and aids in the accurate and early detection of cancer.

According to a Lancet article published in June 2022, the use of AI detection during screening colonoscopies contributed to the avoidance of 7194 new cases and 2089 fatalities from colorectal cancer in 2022.

Additionally, this market is anticipated to experience considerable growth prospects due to the potential for growth in emerging economies and the rising number of cross-industry alliances and collaborations.

For instance: The only germline test currently recognised by the FDA as a companion diagnostic for the management of HER2 negative high-risk early-stage breast cancer is BRACAnalysis CDx

Whiterabbit.ai and Arterys signed a deal in August 2022 to upgrade AI-generated technologies and find cancer at an early stage.

Roche and EarlySign approved a partnership in July 2022 to market and oversee their LungFlag technology. Their alliance's main goal is to make early lung cancer diagnoses widely available to the general public.

global ai for early cancer diagnostics market

Global AI for Early Cancer Diagnostics Market: By Component

The software solutions segment is expected to be the largest & fastest-growing segment in the market from 2023-2028. The introduction of software solutions by market participants for the diagnosis of cancer is responsible for the segment growth. For instance, Paige announced the release of Paige Breast Lymph Node in March 2022. Metastases of any size can be efficiently and precisely identified by the software. Additionally, initiatives done by the major market participants and growing use of AI for diagnostics are anticipated to propel market expansion.

For instance, as part of a public-private partnership plan, Varian, a Siemens Healthineers subsidiary, joined with the state and federal governments of India in June 2022 to establish radiation centres in the states with the highest rates of cancer, hence enhancing the segment expansion.

Global AI for Early Cancer Diagnostics Market: By Cancer Type

The brain tumor segment is anticipated to be the fastest-growing segment in the market from 2023-2028 owing to the increasing incidence of brain tumours among the world's population. In the United States, more than 83,000 people received a brain tumour diagnosis in 2021, according to the America Cancer Journal. Additionally, using AI to diagnose brain tumours speeds up the process since the digital images are produced in a matter of minutes. The AI models also aid in the more accurate diagnosis of cancer.

The most common use of artificial intelligence (AI) methods based on computer-aided diagnostic systems (CADS) is the precise identification of brain cancer. However, because artificial diagnostic tools are inaccurate, health care providers are not efficiently utilising them in the detection of brain cancer.

Global AI for Early Cancer Diagnostics Market: By End-User

The hospital segment is anticipated to be the largest-growing segment in the market from 2023-2028 owing to the increased adoption of AI solutions in hospitals to address the scarcity of healthcare workers and speed up the detection of cancer. For instance, InnerEye, a deep learning tool from Microsoft Research Cambridge, was first used by Addenbrooke's Hospital in Cambridge, United Kingdom. The instrument aids in the precise tumour identification and up to a 90% reduction in CT processing time and treatment planning. The segment's growth is being aided by an increase in the use of AI for more accurate and rapid cancer diagnosis as well as to lower the incidence of false positives and negatives and enhance patient outcomes.

global ai for early cancer diagnostics market

Global AI for Early Cancer Diagnostics Market: By Region

Geographically, the segment of North America is analyzed to be the largest in the market, owing to the rising and rapid acceptance and development of cutting-edge technologies, including cloud computing, artificial intelligence (AI), and machine learning (ML) in the healthcare space. Additionally, it is projected that increased government spending on the healthcare sector will accelerate expansion along with greater awareness in the North American region.

Asia Pacific is predicted to have a rapid growth owing to the increased efforts made by the governments, in order to use AI services to improve patient outcomes. Additionally, the rising number of cancer patients in the area is anticipated to support market expansion. For instance, 800,000 new cases of cancer are discovered in India each year, according to information released by the Ministry of Health and Family Welfare, which is propelling the market expansion in Asia Pacific region.

Global AI for Early Cancer Diagnostics Market Share and Competitor Analysis

The key players covered in the global AI for early cancer diagnostics market report include EarlySign, Microsoft, Flatiron, Path AI, Therapixel, Tempus, Paige AI, Inc, Kheiron Medical Technologies Limited, SkinVision and Cancer Center.ai among others.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Research Methodology

1.1    Research Assumptions

1.2    Research Methodology

1.2.1    Estimates and Forecast Timeline

1.3    Information Procurement

1.3.1    Purchased Database

1.3.2    GME’s Internal Database

1.3.3    Primary Research

1.3.4    Secondary Sources & Third-Party Perspectives

            1.3.4.1    Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website

           1.3.4.2 Secondary Data Sources: World Health Organization

1.4    Information or Data Analysis

1.4.1    Data Analysis Models

1.5    Market End-User & Data Visualization

1.6    Data Validation & Publishing

1.7   Market Model

1.7.1    Model Details

              1.7.1.1 Top-Down Approach

               1.7.1.2 Bottom-Up Approach

1.8    Market Segmentation & Scope

1.9    Market Definition

Chapter 2   Executive Summary

2.1.    Global Market Outlook

2.2     Components Outlook

2.3     Cancer Type Outlook

2.4     End-User Outlook

2.5     Regional Outlook

Chapter 3   Global AI for Early Cancer Diagnostics Market Trend Analysis

3.1. Market Introduction

3.2 Penetration & Growth Prospect Mapping

3.3 Impact of COVID-19 on the AI for Early Cancer Diagnostics Market

3.4 Metric Data on Healthcare Industry

3.5 Market Dynamic

3.5.1 Market Driver Analysis

3.5.2 Market Restraint Analysis

3.5.3 Industry Challenges

3.5.4 Industry Opportunities

3.6    Porter’s Five Analysis

3.6.1 Threat of New Entrants

3.6.2 Threat of New Substitutes

3.6.3 Bargaining Power of Buyers/Suppliers

3.6.4 Intensity of Competitive Rivalry

3.7 Market Entry Strategies

Chapter 4   AI for Early Cancer Diagnostics Market: Components Trend Analysis

4.1   Components: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

4.2     Software Solutions

4.2.1    Market Estimates & Forecast Analysis of Software Solutions Segment, By Region, 2020-2028 (USD Billion)

4.3   Hardware

4.3.1    Market Estimates & Forecast Analysis of Hardware Markets Segment, By Region, 2020-2028 (USD Billion)

4.4   Services

4.4.1    Market Estimates & Forecast Analysis of Services Markets Segment, By Region, 2020-2028 (USD Billion)

Chapter 5   AI for Early Cancer Diagnostics Market: Cancer Type Trend Analysis

5.1    Cancer Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

5.2    Breast Cancer

5.2.1    Market Estimates & Forecast Analysis of Breast Cancer Segment, By Region, 2020-2028 (USD Billion)

5.3     Lung Cancer

5.3.1    Market Estimates & Forecast Analysis of Lung Cancer Segment, By Region, 2020-2028 (USD Billion)

5.4     Prostate Cancer

5.4.1    Market Estimates & Forecast Analysis of Prostate Cancer Segment, By Region, 2020-2028 (USD Billion)

5.5     Colorectal Cancer

5.5.1    Market Estimates & Forecast Analysis of Colorectal Cancer Segment, By Region, 2020-2028 (USD Billion)

5.6     Brain Tumor

5.6.1    Market Estimates & Forecast Analysis of Brain Tumor Segment, By Region, 2020-2028 (USD Billion)

5.7     Others

5.7.1    Market Estimates & Forecast Analysis of Others Segment, By Region, 2020-2028 (USD Billion)

Chapter 6   AI for Early Cancer Diagnostics Market: End-User Trend Analysis

6.1    End-User: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028

6.2    Hospitals

6.2.1    Market Estimates & Forecast Analysis of Hospitals Segment, By Region, 2020-2028 (USD Billion)

6.3    Surgical Centers

6.3.1    Market Estimates & Forecast Analysis of Governance, Surgical Centers Segment, By Region, 2020-2028 (USD Billion)

6.4   Medical Institutes

6.4.1    Market Estimates & Forecast Analysis of Medical Institutes Segment, By Region, 2020-2028 (USD Billion)

6.4   Others

6.4.1    Market Estimates & Forecast Analysis of Others Segment, By Region, 2020-2028 (USD Billion)

Chapter 7   AI for Early Cancer Diagnostics Market, By Region

7.1    Regional Outlook

7.2    North America

7.2.1    Market Estimates & Forecast Analysis, By Country 2020-2028(USD Billion)

7.2.2    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

7.2.3    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

7.2.4    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

7.2.5    U.S.

7.2.5.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

7.2.5.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

7.2.5.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

7.2.6    Canada

7.2.6.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

7.2.6.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

7.2.6.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

7.2.7    Mexico

7.2.7.1    Market Estimates & Forecast Analysis, By Components, 2020-2028 (USD Billion)

7.2.7.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028 (USD Billion)

7.2.7.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028 (USD Billion)

8.3    Europe

8.3.1    Market Estimates & Forecast Analysis, By Country 2020-2028(USD Billion)

8.3.2    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.3.3    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.3.4    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.3.5    Germany

8.3.5.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.3.5.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.3.5.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.3.6    UK

8.3.6.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.3.6.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.3.6.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.3.7    France

8.3.7.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.3.7.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.3.7.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.3.8    Russia

8.3.8.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.3.8.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.3.7.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.3.9    Italy

8.3.9.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.3.9.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.3.9.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.3.10    Spain

8.3.10.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.3.10.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.3.10.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.3.11    Rest of Europe

8.3.11.1    Market Estimates & Forecast Analysis, By Components, 2020-2028 (USD Billion)

8.3.11.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028 (USD Billion)

8.3.11.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028 (USD Billion)

8.4    Asia Pacific

8.4.1    Market Estimates & Forecast Analysis, By Country 2020-2028(USD Billion)

8.4.2    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.4.3    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.4.4    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.4.5    China

8.4.5.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.4.5.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.4.5.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.4.6    India

8.4.6.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.4.6.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.4.6.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.4.8    Japan

8.4.8.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.4.8.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.4.8.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.4.8    Australia

8.4.8.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.4.8.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.4.8.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.4.9    South Korea

8.4.9.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.4.9.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.4.9.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.4.10    Rest of Asia Pacific

8.4.10.1    Market Estimates & Forecast Analysis, By Components, 2020-2028 (USD Billion)

8.4.10.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028 (USD Billion)

8.4.10.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028 (USD Billion)

8.5    Central & South America

8.5.1    Market Estimates & Forecast Analysis, By Country 2020-2028(USD Billion)

8.5.2    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.5.3    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.5.4   Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.5.5    Brazil

8.5.5.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.5.5.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.5.5.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.5.6    Rest of Central & South America

8.5.6.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.5.6.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.5.6.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.6    Middle East & Africa

8.6.1    Market Estimates & Forecast Analysis, By Country 2020-2028(USD Billion)

8.6.2    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.6.3    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.6.4    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.6.5    Saudi Arabia

8.6.5.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.6.5.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.6.5.3   Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.6.6    United Arab Emirates

8.6.6.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.6.6.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.6.6.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.6.7    South Africa

8.6.7.1    Market Estimates & Forecast Analysis, By Components, 2020-2028(USD Billion)

8.6.7.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028(USD Billion)

8.6.7.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028(USD Billion)

8.6.8   Rest of Middle East & Africa

8.6.8.1    Market Estimates & Forecast Analysis, By Components, 2020-2028 (USD Billion)

8.6.8.2    Market Estimates & Forecast Analysis, By Cancer Type, 2020-2028 (USD Billion)

8.6.8.3    Market Estimates & Forecast Analysis, By End-User, 2020-2028 (USD Billion)

Chapter 9   Competitive Analysis

9.1    Key Global Players, Recent Developments & their Impact on the Industry

9.2    Four Quadrant Competitor Positioning Matrix

9.2.1    Key Innovators

9.2.2    Market Leaders

9.2.3    Emerging Players

9.2.4    Market Challengers

9.3    Vendor Landscape Analysis

9.4    End-User Landscape Analysis

9.5    Company Market Share Analysis, 2022

Chapter 10   Company Profile Analysis

10.1    Competitive Analysis, 2022

10.2    EarlySign

10.2.1    Company Overview

10.2.2    Financial Analysis

10.2.3    Strategic Positioning

10.2.4    Info Graphic Analysis

10.3    Microsoft

10.3.1    Company Overview

10.3.2    Financial Analysis

10.3.3    Strategic Positioning

10.3.4    Info Graphic Analysis

10.4     Flatiron

10.4.1    Company Overview

10.4.2    Financial Analysis

10.4.3    Strategic Positioning

10.4.4    Info Graphic Analysis

10.5     Path AI

10.5.1    Company Overview

10.5.2    Financial Analysis

10.5.3    Strategic Positioning

10.5.4    Info Graphic Analysis

10.6    Therapixel

10.6.1    Company Overview

10.6.2    Financial Analysis

10.6.3    Strategic Positioning

10.6.4    Info Graphic Analysis

10.7    Tempus

10.7.1    Company Overview

10.7.2    Financial Analysis

10.7.3    Strategic Positioning

10.7.4    Info Graphic Analysis

10.8    Paige AI, Inc

10.8.1    Company Overview

10.8.2    Financial Analysis

10.8.3    Strategic Positioning

10.8.4    Info Graphic Analysis

10.9 Kheiron Medical Technologies Limited

10.9.1    Company Overview

10.9.2    Financial Analysis

10.9.3    Strategic Positioning

          10.9.4    Info Graphic Analysis

10.10 SkinVision

10.10.1    Company Overview

10.10.2    Financial Analysis

10.10.3    Strategic Positioning

          10.10.4    Info Graphic Analysis

10.11 Cancer Center.ai

10.11.1    Company Overview

10.11.2    Financial Analysis

10.11.3    Strategic Positioning

          10.11.4    Info Graphic Analysis

10.12 Other Players

10.16.1    Company Overview

10.16.2    Financial Analysis

10.16.3    Strategic Positioning

          10.16.4    Info Graphic Analysis

List of Tables

1 Technological Advancements In AI for Early Cancer Diagnostics Market

2 Global AI for Early Cancer Diagnostics Market: Key Market Drivers

3 Global AI for Early Cancer Diagnostics Market: Key Market Challenges

4 Global AI for Early Cancer Diagnostics Market: Key Market Opportunities

5 Global AI for Early Cancer Diagnostics Market: Key Market Restraints

6 Global AI for Early Cancer Diagnostics Market Estimates & Forecast Analysis, 2020-2028 (USD Billion)

7 Global AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

8 Hardware: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

9 Software Solutions: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

10 Services: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

11 Global AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

12 Breast Cancer: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

13 Lung Cancer: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

14 Prostate Cancer: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

15 Colorectal Cancer: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

16 Brain Tumor: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

17 Others: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

18 Global AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

19 Hospitals: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

20 Surgical Centers: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

21 Medical Institutes: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

22 Others: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

23 Regional Analysis: Global AI for Early Cancer Diagnostics Market, By Region, 2020-2028 (USD Billion)

24 North America: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

25 North America: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

26 North America: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

27 North America: AI for Early Cancer Diagnostics Market, By Country, 2020-2028 (USD Billion)

28 U.S: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

29 U.S: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

30 U.S: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

31 Canada: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

32 Canada: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

33 Canada: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

34 Mexico: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

35 Mexico: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

36 Mexico: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

37 Europe: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

38 Europe: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

39 Europe: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

40 Germany: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

41 Germany: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

42 Germany: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

43 UK: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

44 UK: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

45 UK: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

46 France: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

47 France: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

48 France: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

49 Italy: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

50 Italy: AI for Early Cancer Diagnostics Market, By T Cancer Type Cancer Type, 2020-2028 (USD Billion)

51 Italy: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

52 Spain: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

53 Spain: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

54 Spain: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

55 Rest Of Europe: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

56 Rest Of Europe: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

57 Rest of Europe: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

58 Asia Pacific: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

59 Asia Pacific: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

60 Asia Pacific: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

61 Asia Pacific: AI for Early Cancer Diagnostics Market, By Country, 2020-2028 (USD Billion)

62 China: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

63 China: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

64 China: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

65 India: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

66 India: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

67 India: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

68 Japan: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

69 Japan: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

70 Japan: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

71 South Korea: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

72 South Korea: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

73 South Korea: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

74 Middle East & Africa: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

75 Middle East & Africa: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

76 Middle East & Africa: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

77 Middle East & Africa: AI for Early Cancer Diagnostics Market, By Country, 2020-2028 (USD Billion)

78 Saudi Arabia: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

79 Saudi Arabia: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

80 Saudi Arabia: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

81 UAE: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

82 UAE: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

83 UAE: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

84 Central & South America: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

85 Central & South America: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

86 Central & South America: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

87 Central & South America: AI for Early Cancer Diagnostics Market, By Country, 2020-2028 (USD Billion)

88 Brazil: AI for Early Cancer Diagnostics Market, By Components, 2020-2028 (USD Billion)

89 Brazil: AI for Early Cancer Diagnostics Market, By Cancer Type, 2020-2028 (USD Billion)

90 Brazil: AI for Early Cancer Diagnostics Market, By End-User, 2020-2028 (USD Billion)

91 EarlySign: Products Offered

92 Microsoft: Products Offered

93 Flatiron: Products Offered

94 Path AI: Products Offered

95 Therapixel: Products Offered

96 Tempus: Products Offered

97 Paige AI, Inc Inc: Products Offered

98 Kheiron Medical Technologies Limited: Products Offered

99 SkinVision: Products Offered

100 Cancer Center.ai: Products Offered

101 Other Companies: Products Offered

List of Figures

1. Global AI for Early Cancer Diagnostics Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global AI for Early Cancer Diagnostics Market: Penetration & Growth Prospect Mapping

7. Global AI for Early Cancer Diagnostics Market: Value Chain Analysis

8. Global AI for Early Cancer Diagnostics Market Drivers

9. Global AI for Early Cancer Diagnostics Market Restraints

10. Global AI for Early Cancer Diagnostics Market Opportunities

11. Global AI for Early Cancer Diagnostics Market Challenges

12. Key AI for Early Cancer Diagnostics Market Manufacturer Analysis

13. Global AI for Early Cancer Diagnostics Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. EarlySign: Company Snapshot

16. EarlySign: SWOT Analysis

17. Microsoft: Company Snapshot

18. Microsoft: SWOT Analysis

19. Flatiron: Company Snapshot

20. Flatiron: SWOT Analysis

21. Path AI: Company Snapshot

22. Path AI: SWOT Analysis

23. Therapixel: Company Snapshot

24. Therapixel: SWOT Analysis

25. Tempus: Company Snapshot

26. Tempus: SWOT Analysis

27. Paige AI, Inc Inc: Company Snapshot

28. Paige AI, Inc Inc: SWOT Analysis

29. Kheiron Medical Technologies Limited: Company Snapshot

30. Kheiron Medical Technologies Limited: SWOT Analysis

31. SkinVision: Company Snapshot

32. SkinVision: SWOT Analysis

33. Cancer Center.ai: Company Snapshot

34. Cancer Center.ai: SWOT Analysis

35. Other Companies: Company Snapshot

36. Other Companies: SWOT Analysis

The Global AI for Early Cancer Diagnostics Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the AI for Early Cancer Diagnostics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Frequently Asked Questions

The global AI for early cancer diagnostics market is projected to grow at a CAGR of 29.7% from 2023 to 2028.
The key players covered in the AI for early cancer diagnostics market report are EarlySign, Microsoft, Flatiron, Path AI, Therapixel, Tempus, Paige AI, Inc, Kheiron Medical Technologies Limited, SkinVision and Cancer Center.ai among others.
The opportunities prevailing in the global AI for early cancer diagnostics market is increase in the number of efforts taken by the major market participants and the advent of creative start-ups that create cutting-edge AI solutions for early cancer diagnoses.
The primary factor fuelling the expansion of the global AI For early cancer diagnostics market is the increased spending to contribute to the improvement of the digital infrastructure, which is analyzed to accelerate the use of AI in hospitals and other healthcare facilities.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius